LADENBURG THALMANN FINANCIAL SERVICES INC. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 48 filers reported holding CTI BIOPHARMA CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2019$2,0001,110
+5450.0%
0.00%
Q3 2019$0200.0%0.00%
Q2 2019$0200.0%0.00%
Q1 2019$0200.0%0.00%
Q4 2018$0200.0%0.00%
Q3 2018$0200.0%0.00%
Q2 2018$0200.0%0.00%
Q1 2018$0200.0%0.00%
Q4 2017$0200.0%0.00%
Q3 2017$020
-83.3%
0.00%
Q2 2017$0
-100.0%
1200.0%0.00%
Q1 2017$1,0001200.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,684,404$21,876,0009.07%
Lion Point Capital, LP 5,489,546$25,636,0005.95%
SILVERARC CAPITAL MANAGEMENT, LLC 2,250,000$10,508,0004.35%
Bleichroeder LP 3,859,707$18,025,0003.20%
NEA Management Company, LLC 7,140,450$99,804,0002.88%
BVF INC/IL 8,929,690$41,702,0001.67%
Ghost Tree Capital, LLC 1,300,000$6,071,0001.32%
EAM Investors, LLC 1,011,935$4,726,0000.88%
Knott David M Jr 556,687$2,600,0000.83%
Sofinnova Investments, Inc. 1,952,691$9,119,0000.69%
View complete list of CTI BIOPHARMA CORP shareholders